AbbVie Inc.

AbbVie Inc. is a global biopharma specializing in immunology, oncology, and neurology. Core assets include Humira, Imbruvica, Skyrizi, Rinvoq, and a robust pipeline of therapies across autoimmune, blood cancers, and rare diseases.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 55,000
HQ: North Chicago

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
ABBV	AbbVie Inc. Cap: 394.1B \| P/E: 166.4	EQUITY	NYQ	USD	US00287Y1091	Active	📈